Y Intercept Hong Kong Ltd Takes Position in Mettler-Toledo International Inc. (NYSE:MTD)

Y Intercept Hong Kong Ltd acquired a new stake in Mettler-Toledo International Inc. (NYSE:MTD) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 674 shares of the medical instruments supplier’s stock, valued at approximately $825,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Union Bancaire Privee UBP SA purchased a new position in shares of Mettler-Toledo International in the fourth quarter valued at approximately $1,616,000. Suncoast Equity Management lifted its stake in Mettler-Toledo International by 10.7% in the fourth quarter. Suncoast Equity Management now owns 509 shares of the medical instruments supplier’s stock worth $623,000 after acquiring an additional 49 shares during the last quarter. Boston Financial Mangement LLC lifted its stake in Mettler-Toledo International by 12.8% in the fourth quarter. Boston Financial Mangement LLC now owns 7,429 shares of the medical instruments supplier’s stock worth $9,091,000 after acquiring an additional 843 shares during the last quarter. Handelsbanken Fonder AB lifted its stake in Mettler-Toledo International by 14.3% in the fourth quarter. Handelsbanken Fonder AB now owns 12,913 shares of the medical instruments supplier’s stock worth $15,801,000 after acquiring an additional 1,618 shares during the last quarter. Finally, Truist Financial Corp lifted its stake in Mettler-Toledo International by 1.3% in the fourth quarter. Truist Financial Corp now owns 1,053 shares of the medical instruments supplier’s stock worth $1,289,000 after acquiring an additional 14 shares during the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Insider Transactions at Mettler-Toledo International

In other news, insider Gerry Keller sold 600 shares of the company’s stock in a transaction on Monday, February 10th. The shares were sold at an average price of $1,351.34, for a total transaction of $810,804.00. Following the transaction, the insider now directly owns 6 shares of the company’s stock, valued at $8,108.04. This represents a 99.01 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Christian Magloth sold 790 shares of the business’s stock in a transaction dated Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the completion of the sale, the insider now owns 734 shares in the company, valued at $964,248.46. This represents a 51.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 1,530 shares of company stock valued at $2,024,192 in the last ninety days. 1.94% of the stock is currently owned by company insiders.

Mettler-Toledo International Stock Down 2.6 %

NYSE:MTD opened at $1,256.11 on Friday. Mettler-Toledo International Inc. has a fifty-two week low of $1,142.91 and a fifty-two week high of $1,546.93. The stock has a market cap of $26.27 billion, a PE ratio of 30.99, a price-to-earnings-growth ratio of 3.30 and a beta of 1.13. The firm’s fifty day simple moving average is $1,290.38 and its 200-day simple moving average is $1,330.97.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, topping analysts’ consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. Equities analysts anticipate that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current year.

Wall Street Analyst Weigh In

MTD has been the subject of a number of recent research reports. Robert W. Baird lifted their price target on shares of Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a “neutral” rating in a research note on Monday, February 10th. Wolfe Research initiated coverage on shares of Mettler-Toledo International in a research note on Friday, December 13th. They issued a “peer perform” rating for the company. Evercore ISI lifted their price target on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an “outperform” rating in a research note on Monday, February 10th. Citigroup upgraded shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and boosted their price objective for the stock from $1,200.00 to $1,300.00 in a research report on Wednesday, December 11th. Finally, Wells Fargo & Company boosted their price objective on shares of Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the stock an “equal weight” rating in a research report on Monday, February 10th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $1,368.00.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.